The House of Representatives' Committee on Good Government and Public Accountability was asked to see if certain laws were violated by the Food and Drug Administration (FDA) for the agency's receipt of private funding.
The committee terminated on June 9 its inquiry into the issue and is expected to come up with its report.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.